STOK stock

Jefferies analysts initates a Buy rating for Stoke Therapeutics Inc (STOK)
Roman Campbell
Stoke Therapeutics Inc’s recent filing unveils that its Director Kaye Edward M. MD unloaded Company’s shares for reported $0.75 million ...

Stoke Therapeutics Inc’s recent filing unveils that its Director Kaye Edward M. MD unloaded Company’s shares for reported $0.75 million ...